Medicines ATC group B02BD02, active substance Coagulation factor VIII

Auto-translated from sk

Original title: Lieky ATC skupiny B02BD02, účinná látka Koagulačný faktor VIII

Všeobecná zdravotná poisťovňa, a.s.

Published: Sep 24, 2026

Updated: Sep 24, 2026

Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Slovakia, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Original language: sk

This tender, originating from Slovakia and available on TED, concerns the procurement of medicines specifically classified under ATC group B02BD02, identified by the active substance Coagulation Factor VIII. Coagulation Factor VIII is a vital protein used in the treatment of hemophilia A. The contracting authority is seeking a reliable supplier for this critical pharmaceutical product. Typical requirements for such a tender include adherence to stringent pharmaceutical quality standards (e.g., GMP - Good Manufacturing Practice) and regulatory requirements set by Slovak and European health authorities. Bidders must be authorized to distribute and supply pharmaceuticals. The tender will likely specify the required dosage forms, packaging sizes, and quantities. Emphasis will be placed on the security and continuity of supply, ensuring the availability of this life-saving medication. Evaluation criteria will include the price per unit, the supplier's ability to guarantee uninterrupted supply, the product's expiry date, and compliance with all relevant pharmacovigilance and regulatory obligations. Experience in supplying specialized pharmaceuticals to national health systems or hospitals would be highly valued.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on September 24, 2026. Last refreshed today. Original language: sk. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Všeobecná zdravotná poisťovňa, a.s.

Všeobecná zdravotná poisťovňa, a.s. has issued 61 procurement notices on BidsFactory, including 4 currently open and 30 awarded contracts. Activity concentrates in Health & Medical, Information & Communication Technology, and General Supplies & Services. All notices are published for Slovakia. Notices are distributed via TED - Tenders Electronic Daily (EU). Most recent publication: September 24, 2026.

Frequently asked questions about this tender

Where will the contract be performed?

The contract is for delivery in Slovakia. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Who is the contracting authority?

This notice was issued by Všeobecná zdravotná poisťovňa, a.s. in Slovakia. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.